29.01.2024 - 31.01.2024Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 am - 3:45 pm
Conference themes Advance Scalability, Accessibility and Affordability of Autologous Cell Therapies
As the cell therapy space bears witness to an increasing number of autologous therapies gaining regulatory approval, the essential role of the manufacturing ecosystem has never been clearer. It is business critical for cell therapy drug developers to have a robust strategy for scale up whilst overcoming the labour and cost intensive nature of batch manufacturing to reduce the cost of goods.
Speakers: Richard McFarland, Chief Regulatory Officer, Advanced Regenerative Manufacturing Institute, Scott Berger, Principal Consultant, Advanced Cell and Gene Therapy, and more.